Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Junaid Tariq

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
EXCLI Journal|January 26, 2026
Recent FDA-approved kinase inhibitors for cancer therapy in 2025: A comprehensive review and perspectivesMateen Abbas, Syed Hassam Ali Sami, Márió Gajdács, et al.
ACS Chemical Neuroscience|February 3, 2026
4-Chlorobenzylamine Containing Maleic Acid Derivatives: Synthesis, <i>In Silico</i> Studies, and Anti-Alzheimer's ActivityMuhammad Junaid Tariq, Madiha Kanwal, Athar Ata, et al.
Cancer Investigation|April 17, 2026
Differential Toxicity of Immune Checkpoint Inhibitors in Older Adults: A Large-Scale, Propensity Score-Matched Real-World AnalysisMuhammad Awidi, Muntaser Al Zyoud, Noor S Bader, et al.
Proceedings (Baylor University. Medical Center)|January 4, 2024
Independent predictors of mortality and 5-year trends in mortality and resource utilization in hospitalized patients with diffuse large B cell lymphomaZubair Hassan Bodla, Mariam Hashmi, Fatima Niaz, et al.
Journal of Community Hospital Internal Medicine Perspectives|August 28, 2020
Evidence-based supportive care in multiple myelomaAnum Qureshi, Muhammad Junaid Tariq, Zunairah Shah, et al.
The Journal of Pharmacy and Pharmacology|October 15, 2024
Pyrazolone-nicotinic acid derivative (4Z)-4-(2-hydroxybenzylidine)-5-methyl-2-(pyridine-3-ylcarbonyl)-2, 4-dihydro-3H-pyrazole-3-one (IIc) as multitarget inhibitor of neurodegeneration and behavioural impairment in DementiaMadiha Kanwal, Sadia Sarwar, Humaira Nadeem, et al.
International Journal of Molecular Sciences|June 19, 2024
Current Novel Targeted Therapeutic Strategies in Multiple MyelomaCindy Hsin-Ti Lin, Muhammad Junaid Tariq, Fauzia Ullah, et al.
Current Treatment Options in Oncology|September 3, 2018
Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail PatientsAbhijeet Kumar, Muhammad Asad Fraz, Muhammad Usman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2019
Revisiting Role of Vaccinations in Donors, Transplant Recipients, Immunocompromised Hosts, Travelers, and Household Contacts of Stem Cell Transplant RecipientsAneela Majeed, Zoey Harris, Eric Brucks, et al.
Immunotherapy|February 22, 2019
Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature reviewSeren Durer, Ceren Durer, Madeeha Shafqat, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
EXCLI Journal|January 26, 2026
Recent FDA-approved kinase inhibitors for cancer therapy in 2025: A comprehensive review and perspectivesMateen Abbas, Syed Hassam Ali Sami, Márió Gajdács, et al.
ACS Chemical Neuroscience|February 3, 2026
4-Chlorobenzylamine Containing Maleic Acid Derivatives: Synthesis, <i>In Silico</i> Studies, and Anti-Alzheimer's ActivityMuhammad Junaid Tariq, Madiha Kanwal, Athar Ata, et al.
Cancer Investigation|April 17, 2026
Differential Toxicity of Immune Checkpoint Inhibitors in Older Adults: A Large-Scale, Propensity Score-Matched Real-World AnalysisMuhammad Awidi, Muntaser Al Zyoud, Noor S Bader, et al.
Proceedings (Baylor University. Medical Center)|January 4, 2024
Independent predictors of mortality and 5-year trends in mortality and resource utilization in hospitalized patients with diffuse large B cell lymphomaZubair Hassan Bodla, Mariam Hashmi, Fatima Niaz, et al.
Journal of Community Hospital Internal Medicine Perspectives|August 28, 2020
Evidence-based supportive care in multiple myelomaAnum Qureshi, Muhammad Junaid Tariq, Zunairah Shah, et al.
The Journal of Pharmacy and Pharmacology|October 15, 2024
Pyrazolone-nicotinic acid derivative (4Z)-4-(2-hydroxybenzylidine)-5-methyl-2-(pyridine-3-ylcarbonyl)-2, 4-dihydro-3H-pyrazole-3-one (IIc) as multitarget inhibitor of neurodegeneration and behavioural impairment in DementiaMadiha Kanwal, Sadia Sarwar, Humaira Nadeem, et al.
International Journal of Molecular Sciences|June 19, 2024
Current Novel Targeted Therapeutic Strategies in Multiple MyelomaCindy Hsin-Ti Lin, Muhammad Junaid Tariq, Fauzia Ullah, et al.
Current Treatment Options in Oncology|September 3, 2018
Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail PatientsAbhijeet Kumar, Muhammad Asad Fraz, Muhammad Usman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2019
Revisiting Role of Vaccinations in Donors, Transplant Recipients, Immunocompromised Hosts, Travelers, and Household Contacts of Stem Cell Transplant RecipientsAneela Majeed, Zoey Harris, Eric Brucks, et al.
Immunotherapy|February 22, 2019
Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature reviewSeren Durer, Ceren Durer, Madeeha Shafqat, et al.
Pageof 2